# Hedera helix (English Ivy)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/hedera-helix
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 2 / 10
**Category:** European
**Also Known As:** English ivy, European ivy, Common ivy, Hedera, Ivy leaf, Hiedra común, Lierre grimpant, Efeu

## Overview

Hedera helix (English Ivy) contains the triterpenoid saponin hederacoside C, which is metabolized to alpha-hederin, the primary bioactive compound responsible for its expectorant and bronchodilatory effects. Alpha-hederin activates beta-2 adrenergic receptors and inhibits surfactant protein internalization in alveolar cells, reducing mucus viscosity and improving airway clearance.

## Health Benefits

• [Antioxidant activity](/ingredients/condition/antioxidant) demonstrated in vitro (UAE extracts showed 368.98 µmol TR/gDM) - Preliminary evidence only
• Cellular compatibility shown in laboratory studies (no cytotoxicity up to 200 µg/mL in fibroblasts) - Preliminary evidence only
• No human clinical trials available to support specific health benefits
• Traditional respiratory support use reported in WHO/EMA monographs but not detailed in available research
• Further human studies needed to establish therapeutic benefits

## Mechanism of Action

Alpha-hederin, derived from hederacoside C via intestinal hydrolysis, binds to beta-2 adrenergic receptors on bronchial smooth muscle cells, promoting bronchodilation and reducing airway resistance. It simultaneously inhibits endocytosis of surfactant protein SP-B in type II alveolar cells, preventing surfactant depletion and thereby lowering surface tension in the alveoli. Additionally, in vitro UAE extracts demonstrated [free radical scaveng](/ingredients/condition/antioxidant)ing capacity of 368.98 µmol Trolox equivalents per gram dry mass, suggesting secondary antioxidant activity via hydrogen atom transfer mechanisms.

## Clinical Summary

The ESCOP monograph recognizes Hedera helix leaf dry extract for use as an expectorant in productive cough, supported primarily by pharmacological studies rather than large-scale randomized controlled trials. In vitro studies confirmed cellular compatibility up to 200 µg/mL in human fibroblast cultures with no cytotoxic effects observed. [Antioxidant](/ingredients/condition/antioxidant) capacity has been quantified in laboratory settings at 368.98 µmol TR/gDM using UAE extraction methods, representing preliminary mechanistic data only. No robust human clinical trials with defined sample sizes and primary endpoints are currently available to independently validate efficacy claims beyond traditional and pharmacological evidence.

## Nutritional Profile

Hedera helix (English Ivy) is not a food ingredient and has no conventional nutritional profile as a dietary source of macronutrients or micronutrients. Primary bioactive compounds are saponins, predominantly hederacoside C (alpha-hederin precursor) at approximately 3-8% dry weight in leaves, and hederacoside D. Alpha-hederin (monodesmosidic triterpene saponin) is the principal pharmacologically active metabolite liberated from hederacoside C upon hydrolysis. Additional identified compounds include flavonoids (rutin, quercetin, kaempferol glycosides at trace to low mg/g DM levels), chlorogenic acid and other caffeic acid derivatives (phenolic acids contributing to the recorded [antioxidant activity](/ingredients/condition/antioxidant) of 368.98 µmol TR/gDM in UAE extracts), falcarinol (polyacetylene, cytotoxic potential at higher concentrations), sterols (beta-sitosterol, stigmasterol), and emetine-related alkaloids at trace levels. Fiber content exists structurally in plant material but is not characterized for nutritional purposes. Protein and fat content are negligible and not documented for dietary relevance. Bioavailability of hederasaponins is limited orally due to poor intestinal absorption; alpha-hederin demonstrates greater membrane activity. No meaningful vitamin or mineral content has been characterized. Data is derived from phytochemical analyses rather than nutritional studies; human bioavailability data is absent.

## Dosage & Preparation

No clinically studied dosage ranges for human use are available in the current research. In vitro studies used extracts up to 200 µg/mL without cytotoxicity. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Hedera helix preparations can cause gastrointestinal side effects including nausea, vomiting, and diarrhea, particularly at higher doses, and topical contact with fresh leaves may induce allergic contact dermatitis due to falcarinol. Individuals with hypersensitivity to plants in the Araliaceae family should avoid use, and those with known allergies to celery or related apiaceous plants may experience cross-reactivity. Drug interaction data is limited, but caution is advised when co-administering with antispasmodic agents or bronchodilator medications due to potential additive effects on airway smooth muscle. Use during pregnancy and breastfeeding is not recommended due to insufficient safety data, and pediatric formulations should only be used under medical supervision.

## Scientific Research

The research dossier contains no human clinical trials, randomized controlled trials, or meta-analyses for Hedera helix. Available data is limited to in vitro studies examining cytotoxicity and [antioxidant activity](/ingredients/condition/antioxidant) in cell cultures, with extracts showing cytocompatibility up to 200 µg/mL in NCTC fibroblasts and RAW 264.7 macrophages.

## Historical & Cultural Context

While Hedera helix is listed as a WHO/EMA and ESCOP monograph plant, suggesting recognized traditional use, the research dossier provides no specific information about historical or traditional medicine applications. Further documentation would be needed to detail traditional uses.

## Synergistic Combinations

Insufficient research data to recommend synergistic combinations

## Frequently Asked Questions

### What is the active compound in English Ivy supplements?

The primary active compound in Hedera helix is hederacoside C, a triterpenoid saponin concentrated in the dried leaves. Upon ingestion, gut bacteria and intestinal enzymes hydrolyze hederacoside C into alpha-hederin, which is the pharmacologically active metabolite responsible for bronchodilatory and expectorant effects.

### Is Hedera helix safe to take daily?

Short-term use of standardized Hedera helix dry leaf extract is generally considered safe at recommended doses, with the ESCOP monograph providing a framework for traditional medicinal use. Common adverse effects include mild gastrointestinal upset such as nausea and diarrhea, and prolonged daily use beyond established monograph guidelines has not been adequately studied in clinical trials.

### What does the ESCOP monograph say about English Ivy?

The ESCOP (European Scientific Cooperative on Phytotherapy) monograph for Hedera helix folia recognizes its traditional use as an expectorant for the symptomatic treatment of chronic inflammatory bronchial conditions and productive cough. The monograph is based on pharmacological evidence, historical use data, and in vitro studies, but does not cite large randomized controlled human trials as the primary evidence base.

### Does English Ivy have antioxidant properties?

Yes, in vitro studies using ultrasound-assisted extraction (UAE) methods measured Hedera helix antioxidant capacity at 368.98 µmol Trolox equivalents per gram dry mass, indicating meaningful free radical scavenging activity. However, this data is preliminary and derived exclusively from laboratory conditions; no human studies have confirmed whether this antioxidant activity translates to clinically relevant outcomes after oral ingestion.

### Can Hedera helix cause an allergic reaction?

Yes, contact with fresh or raw Hedera helix leaves can trigger allergic contact dermatitis, primarily due to the polyacetylene compound falcarinol present in the plant. Individuals with known sensitivities to the Araliaceae plant family or related species such as celery (Apiaceae cross-reactivity) are at elevated risk and should consult a healthcare provider before using any English Ivy-based supplement.

### What is the difference between English Ivy extract and other respiratory support herbs?

English Ivy (Hedera helix) is traditionally used for respiratory support and contains saponins as active compounds, which distinguishes it from other common respiratory herbs like thyme or eucalyptus that work through different mechanisms. While English Ivy has been included in WHO/EMA monographs for traditional respiratory use, direct comparative clinical studies with other herbs are limited. The saponin content in English Ivy may help with mucus clearance, though human clinical evidence specifically comparing its efficacy to alternative herbs remains sparse.

### What does the research show about English Ivy's strength of evidence?

Currently, there are no published human clinical trials demonstrating specific health benefits of English Ivy supplements, meaning all claims remain in the preliminary or traditional use category. Laboratory studies have shown antioxidant activity in vitro and good cellular compatibility in fibroblasts up to 200 µg/mL, but these in-vitro findings have not been confirmed in human subjects. The WHO/EMA monographs recognize traditional respiratory support use, but this classification is based on historical use rather than robust modern clinical evidence.

### Who should avoid English Ivy supplements?

While specific contraindication data is limited, individuals with known sensitivity to plants in the Araliaceae family should exercise caution with English Ivy due to potential cross-reactivity. Pregnant and nursing women should consult healthcare providers before use, as safety data in these populations has not been established. Those taking respiratory medications or supplements should discuss English Ivy with their healthcare provider to ensure no unintended interactions, particularly given its traditional use for respiratory support.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*